DEXCHLORPHENIRAMINE MALEATE: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-04	118 mL in 1 BOTTLE, PLASTIC (15370-150-04)	2018-10-07
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-16	473 mL in 1 BOTTLE, PLASTIC (15370-150-16)	2018-10-07
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-99	20 mL in 1 BOTTLE, PLASTIC (15370-150-99)	2018-10-07
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	BluCrest Pharmaceuticals LLC	73684-300-08	237 mL in 1 BOTTLE, PLASTIC (73684-300-08)	2025-10-22
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 6, 2025

Introduction

Dexchlorpheniramine maleate is an effective antihistamine widely used to treat allergic conditions such as hay fever, rhinitis, urticaria, and other hypersensitive reactions. It is the dextrorotatory enantiomer of chlorpheniramine, providing similar therapeutic effects with a potentially better side-effect profile. Its global demand has prompted a diverse supply chain comprising active pharmaceutical ingredient (API) manufacturers, excipient suppliers, and finished drug formulators. This article provides a comprehensive overview of key suppliers across the pharmaceutical supply chain for dexchlorpheniramine maleate, emphasizing their market positioning, manufacturing capabilities, and distribution reach.

Market Overview of Dexchlorpheniramine Maleate Suppliers

The supply chain for dexchlorpheniramine maleate spans multiple regions, including Asia, Europe, North America, and India. These regions house the majority of API producers, with India and China emerging as dominant suppliers due to cost advantages and manufacturing scale. International pharmaceutical companies also import finished formulations or API intermediates from these regions, reinforcing global supply network resilience.

Understanding the key suppliers involves evaluating their API manufacturing capabilities, compliance with international standards (such as cGMP, ISO), and the robustness of their distribution channels.

Major API Manufacturers

1. Synthesis and Manufacturing Giants in India and China

India’s pharmaceutical sector plays a pivotal role, with several firms producing dexchlorpheniramine maleate API.

Glenmark Pharmaceuticals: An Indian global pharmaceutical company, Glenmark is known for its extensive API manufacturing capabilities. They produce a variety of antihistamines, including dexchlorpheniramine maleate, adhering to strict cGMP standards and supplying both domestic and international markets. Their manufacturing facilities are approved by regulatory authorities such as USFDA, EMA, and WHO.
Aurobindo Pharma: This India-based manufacturer offers a broad portfolio of generic APIs, including dexchlorpheniramine maleate. Aurobindo emphasizes quality compliance, with several manufacturing sites certified by major regulatory bodies, making it a reliable source globally.
Indo Amines Ltd.: Specializes in the production of intermediates and APIs, including antihistamines. Their focus on quality and process optimization ensures consistent supply of dexchlorpheniramine maleate.
Shandong Xinhua Pharmaceutical Co., Ltd. (China): One of China's leading API producers, offering dexchlorpheniramine maleate with high-volume manufacturing capacity, supported by ISO and GMP certifications. Their competitive pricing and extensive export network make them prominent global suppliers.
Hubei Fuxin Pharmaceutical Co., Ltd. (China): Offers dexchlorpheniramine maleate API, with a focus on quality controls aligned with international standards, serving markets across Asia, Africa, and Latin America.

2. European and North American API Suppliers

While most manufacturing occurs in Asia, certain European and North American firms supply dexchlorpheniramine maleate API or finished formulations.

BASF SE (Germany): A leading global chemical and pharmaceutical ingredients provider, BASF supplies a range of pharmaceutical APIs, including antihistamines. Its rigorous quality standards and extensive distribution network make it a trusted supplier for international pharmaceutical companies.
Sanofi (France/USA): Sanofi produces finished dosage forms and APIs. While their core focuses include innovative therapies, their API manufacturing unit supplies antihistamine APIs, including dexchlorpheniramine maleate, to global pharma clients.
Fresenius Kabi (Germany): Specializes in injectable and sterile APIs. They source or produce dexchlorpheniramine maleate for specific formulations, primarily for hospital use in Europe and North America.

Contract Manufacturing and Importers

Several contract manufacturing organizations (CMOs) and importers serve as integral links in the API supply chain:

Hetero Labs: An India-based CMO with global reach, Hetero produces and supplies dexchlorpheniramine maleate API to multinational companies under OEM arrangements.
Dr. Reddy’s Laboratories: Both a manufacturer of APIs and finished formulations, Dr. Reddy’s supplies dexchlorpheniramine maleate to various markets, emphasizing quality and regulatory compliance.
Trade Brokers and Distributors: Numerous third-party brokers facilitate the international trade of dexchlorpheniramine maleate API, often sourcing from China or India and distributing to global pharmaceutical companies.

Finished Formulation Suppliers

Apart from API manufacturers, several companies produce finished antihistamine products containing dexchlorpheniramine maleate:

Mylan (USA): Manufactures antihistamine tablets and syrup formulations incorporating dexchlorpheniramine maleate for multiple markets.
Sun Pharmaceutical Industries Ltd.: Offers over-the-counter and prescription antihistamine formulations globally.
Krka: A European company producing various OTC antihistamines incorporating dexchlorpheniramine maleate.
Zhejiang Hisun Pharmaceutical Co., Ltd. (China): Produces finished pharmaceuticals sold across Asia, including antihistamine tablets.

Key Factors in Supplier Selection

Regulatory Compliance: Suppliers should possess global quality certifications such as cGMP, ISO, USFDA, EMA, or WHO approval.
Manufacturing Capacity: Large-scale production ensures supply stability amid fluctuating demand.
Pricing and Lead Times: Competitive pricing with reliable lead times is vital in supply chain planning.
Geographic Considerations: Proximity to downstream markets can reduce shipping time and costs.
Reputation for Quality: Suppliers with strong quality track records mitigate risks of regulatory issues.

Supply Chain and Distribution Dynamics

The global infrastructure for dexchlorpheniramine maleate involves sourcing from high-volume API manufacturers primarily in India and China, with European and North American companies supplementing with advanced quality assurance. Finished formulations are assembled across several regions, with global distributors ensuring timely delivery to hospitals, clinics, and pharmacies. The ongoing impact of geopolitical developments, regulatory harmonization efforts, and fluctuations in raw material costs influence sourcing strategies.

Regulatory Landscape and Quality Assurance

Regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and the World Health Organization (WHO) enforce strict standards for API quality, manufacturing practices, and documentation. Manufacturers complying with these standards are preferred, especially for export markets. Importers and distributors must perform rigorous supplier audits, verify certifications, and validate product quality throughout the supply chain.

Key Takeaways

Asian API manufacturers, notably in India and China, dominate the dexchlorpheniramine maleate market due to cost efficiencies, large production capacities, and expanding export networks.
European and North American suppliers mainly produce finished formulations or sterile APIs with high regulatory standards.
Trustworthy suppliers demonstrate compliance with regulatory standards, hold multiple certifications, maintain robust manufacturing capacity, and adhere to quality control protocols.
The choice of supplier hinges on regulatory compliance, quality assurance, cost, and logistics considerations.
Global supply chains for dexchlorpheniramine maleate are sensitive to geopolitical shifts, trade policies, and raw material costs, demanding continuous supplier evaluation and risk management.

FAQs

1. What are the primary regions sourcing dexchlorpheniramine maleate API?
India and China are the leading sources of dexchlorpheniramine maleate API, supplying a significant portion of the global demand due to their manufacturing scale and competitive pricing. European and North American suppliers are more involved in finished formulations or specialized APIs.

2. How does regulatory compliance affect supplier selection?
Regulatory compliance ensures product quality, safety, and efficacy, vital for market approval in strict jurisdictions like the US and Europe. Suppliers with certifications such as cGMP, FDA approval, or WHO prequalification are preferred to mitigate regulatory risks.

3. Are there concerns about quality risks in sourcing from Asian manufacturers?
While many Asian manufacturers meet stringent international standards, due diligence through audits, certifications, and batch testing remains essential to ensure consistent quality and compliance with regulatory requirements.

4. How has the COVID-19 pandemic impacted the supply chain for dexchlorpheniramine maleate?
Disruptions in logistics, raw material shortages, and increased demand for antihistamines have accentuated supply chain vulnerabilities, prompting manufacturers to diversify sourcing strategies and stockpile inventory.

5. Can finished pharmaceutical formulations be sourced directly from API suppliers?
Yes; many API suppliers either produce finished formulations or collaborate with CMOs to supply finished dosage forms directly. However, purchasing finished products entails different regulatory and quality considerations compared to raw APIs.

References

[1] US Food and Drug Administration (FDA). Guide to Pharmaceutical Quality Systems. 2022.
[2] Indian Drug Manufacturers Association. API Market Reports. 2021.
[3] European Medicines Agency (EMA). Good Manufacturing Practice (GMP) Certification. 2022.
[4] World Health Organization. Prequalification Programme for APIs. 2023.
[5] Market Research Future. "Global Antihistamines Market Analysis." 2022.

Note: Market data, company details, and regulatory status are subject to change; continuous verification is recommended for procurement decisions.

Suppliers and packagers for generic pharmaceutical drug: DEXCHLORPHENIRAMINE MALEATE